article_snippet: There is growing evidence of weak benefits along with serious problems with rosuvastatin although it is the best statin for lowering cholesterol, says Dr Sidney Wolfe .
article_snippet: There is growing evidence of weak benefits along with serious problems with rosuvastatin although it is the best statin for lowering cholesterol, says Dr Sidney Wolfe.
article_snippet: One has reassured patients on rosuvastatin, saying patients should continue taking it.
article_snippet: Initial approval of rosuvastatin to prevent heart attacks in a very select group of people was based on a study which was stopped early, says Dr Sidney Wolfe.
article_snippet: Professor Peter Weissberg, medical director at the British Heart Foundation, said: ‘Patients taking rosuvastatin should not stop taking Patients taking rosuvastatin.
article_snippet: Patients taking rosuvastatin are on Patients taking rosuvastatin for a very good reason.
article_snippet: Rosuvastatin is more expensive than other statins and is one of the least commonly prescribed in the UK. '
article_snippet: Rosuvastatin is generally prescribed for a small number of people at high risk of a heart attack or stroke and who cannot tolerate the older statins or have not had the desired reduction in cholesterol levels on the older statins.
article_snippet: Dr Wolfe accuses advertising campaigns of exploiting its potency despite ‘long-standing, continuing evidence of rosuvastatin’s comparative lack of clinical benefits and increasing evidence of risk’.
article_snippet: People should continue to take People medicines as prescribed.
highlights_snippet: Rosuvastatin carries a high rate of harmful side-effects, campaigner claims .
  